Monte Rosa Therapeutics, Inc. · NASDAQ:GLUE

Bowen Matthew received 4,300 Monte Rosa Therapeutics, Inc. shares as an award (Form 4)

Traded Apr 6, 2026 · Filed Apr 7, 2026

On Apr 6, 2026, Bowen Matthew (Principal Accounting Officer) received 4,300 Monte Rosa Therapeutics, Inc. shares as an award, leaving 25,904 shares. Filed Apr 7, 2026 (Form 4).

Awarded
4,300 shares
Holding after
25,904 shares
Trading plan
No
Role
Principal Accounting Officer

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Apr 6, 2026Common StockAward4,30025,904Direct

Source

View original at SEC

Related